Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 07/29/21
Genocea to Host Second Quarter 2021 Corporate Update Conference Call & WebcastGlobeNewsWire • 07/22/21
Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for GEN-011 Neoantigen-Targeted T cell TherapyGlobeNewsWire • 07/13/21
Is the Options Market Predicting a Spike in Genocea (GNCA) Stock?Zacks Investment Research • 07/07/21
Genocea Presents Promising Long-term Results from GEN-009 Neoantigen Vaccine Phase 1 Trial at ASCO 2021GlobeNewsWire • 06/04/21
Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/29/21
Genocea Biosciences (GNCA) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 04/29/21
Genocea To Host First Quarter 2021 Corporate Update Conference Call & WebcastGlobeNewsWire • 04/22/21
Genocea to Present Novel Preclinical Inhibigen™ Data at AACR Annual Meeting 2021GlobeNewsWire • 04/10/21
Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/11/21
Genocea to Host Fourth Quarter 2020 Corporate Update Conference Call & WebcastGlobeNewsWire • 02/04/21
Genocea Announces Publication in Cancer Discovery Highlighting the Advantages of Neoantigen Identification with the ATLAS™ PlatformGlobeNewsWire • 01/28/21
Genocea to Participate in the B. Riley Securities' Virtual Oncology Investor ConferenceGlobeNewsWire • 01/19/21
Genocea Presents Positive GEN-009 Clinical Results, Update on GEN-011 Program and New InhibigenTM Mechanism of Action Data at Virtual SITC 2020GlobeNewsWire • 11/09/20
Genocea to Host Investor Call Highlighting New GEN-009 Clinical and Immunogenicity Data to be Presented at Virtual SITC 2020GlobeNewsWire • 11/05/20
Genocea Biosciences, Inc's (GNCA) CEO Chip Clark on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 10/29/20
Genocea to Host Third Quarter 2020 Corporate Update Conference Call & WebcastGlobeNewsWire • 10/22/20
Is Genocea Biosciences (GNCA) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 10/15/20